Recently by Beverly H. Lorell, MD
FDA's New Transparency Task Force: Mission And Opportunity For Public Comment
On June 3, the U.S. Food and Drug Administration (FDA or Agency) announced the formation of the FDA Transparency Task Force (Task Force) to solicit public comments and to promulgate recommendations for enhancing the transparency of the FDA's internal activities and decision-making.1As part of its...
Read More